MiniLuxe Holding Corp (MNLX)
TSX Venture Exchange · Canada · prices in CAD · close of 15 Oct 2026
Key indicators
| Last close | CAD 0.390 |
|---|---|
| 52-week range | 0.275 – 0.420 |
| Return, 1 month / 3 months | +1.3% / +11.4% |
| Return, 1 year / 3 years | +21.9% / +122.9% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 56.2% |
| Worst drawdown (1 year) | -21.4% |
| Average daily value traded | 0.00M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
MiniLuxe Holding Corp is a beauty services company that runs nail salons and studios in the United States. Its locations provide manicures, pedicures, waxing and related personal care services to individual customers, and the company also offers its own line of nail polishes and beauty products. The business is based in the United States and focuses on professional nail care delivered by trained technicians in its own studios.
On this site MiniLuxe Holding Corp appears as a stock on the TSX Venture Exchange (Canada), code MNLX, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
MiniLuxe Holding Corp (MNLX) trades on the TSX Venture Exchange in Canada. It last closed at CAD 0.390 on 15 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 142 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.9% and over the last three months it rose 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.1% | ||
| From 52-week high | -7.1% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.4% | ||
| 6-month return | 11.4% | ||
| 12-month return, skipping the last month | 20.3% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.4% | ||
| Liquidity | 23 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M CAD | ||
| Zero-volume days | 86.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +1.3% |
| 3 months | +11.4% |
| 6 months | +11.4% |
| 1 year | +21.9% |
| 3 years | +122.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.389 / 0.333 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.001 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.